Scambia G, Lovergine S, Masciullo V
Division of Gynecologic Oncology, Catholic University, Rome, Italy.
Oncogene. 2006 Aug 28;25(38):5302-8. doi: 10.1038/sj.onc.1209620.
The retinoblastoma family members--pRb, pRb2/p130 and p107--are tumor suppressor genes involved in controlling four major cellular processes: growth arrest, apoptosis, differentiation and angiogenesis. Molecular genetic studies have identified abnormalities of these tumor suppressor genes in a large proportion of human cancers. These genetic alterations have emerged as significant factors in the pathogenesis and progression of many types of tumors and are therefore likely to provide relevant information to assess risk in cancer patients. There is a pressing clinical need to identify prognostic and predictive factors for patients with cancer, because there is an undeniable importance in being able to determine which patients will have a favorable outcome without further therapy (prognostic factor) and which will need some additional treatment (predictive factor). This review examines the predictive and/or prognostic role of each retinoblastoma family member in human cancer.
视网膜母细胞瘤家族成员——pRb、pRb2/p130和p107——是肿瘤抑制基因,参与控制四个主要细胞过程:生长停滞、细胞凋亡、分化和血管生成。分子遗传学研究已在很大比例的人类癌症中发现这些肿瘤抑制基因存在异常。这些基因改变已成为多种肿瘤发病机制和进展中的重要因素,因此很可能为评估癌症患者的风险提供相关信息。迫切需要确定癌症患者的预后和预测因素,因为能够确定哪些患者无需进一步治疗就能有良好预后(预后因素)以及哪些患者需要一些额外治疗(预测因素)具有不可否认的重要性。本综述探讨了每个视网膜母细胞瘤家族成员在人类癌症中的预测和/或预后作用。